Dyne Therapeutics Inc. (DYN)
17.51
+0.70 (4.16%)
Upcoming Events
Latest Headlines
Form 8-K Dyne Therapeutics, Inc. For: Jun 05
June 8, 2026 4:05 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Jun 03 Filed by: Posner Brian S
June 5, 2026 4:10 PM - SEC Filing
Form 8-K Dyne Therapeutics, Inc. For: Jun 03
June 3, 2026 7:35 AM - SEC Filing
Dyne Therapeutics completes enrollment in myotonic dystrophy trial
June 3, 2026 7:30 AM - StreetInsider
Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1)
June 3, 2026 7:30 AM - StreetInsider
Form 4 Dyne Therapeutics, Inc. For: May 26 Filed by: Posner Brian S
May 28, 2026 4:56 PM - SEC Filing
Dyne Therapeutics submits FDA application for DMD treatment
May 26, 2026 7:31 AM - StreetInsider
Dyne Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)
May 26, 2026 7:30 AM - StreetInsider
Form 4 Dyne Therapeutics, Inc. For: May 20 Filed by: Posner Brian S
May 22, 2026 4:10 PM - SEC Filing
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 20, 2026 5:30 PM - StreetInsider
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 20, 2026 5:30 PM - Globe NewsWire
Dyne starts phase 3 trial of muscular dystrophy drug z-rostudirsen
May 20, 2026 7:46 AM - StreetInsider
Dyne Therapeutics Announces Initiation of Phase 3 FORZETTO Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD) Ahead of Planned BLA Submission for U.S. Accelerated Approval
May 20, 2026 7:46 AM - Globe NewsWire
Form SCHEDULE 13G/A Dyne Therapeutics, Inc. Filed by: JANUS HENDERSON GROUP PLC
May 15, 2026 12:37 PM - SEC Filing
Form SCHEDULE 13G/A Dyne Therapeutics, Inc. Filed by: T. Rowe Price Investment Management, Inc.
May 15, 2026 10:08 AM - SEC Filing
Dyne Therapeutics (DYN) PT Lowered to $33 at Evercore ISI
May 15, 2026 7:15 AM - StreetInsider
Form 4 Dyne Therapeutics, Inc. For: May 13 Filed by: Friedl-Naderer Johanna
May 14, 2026 4:06 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: May 13 Filed by: Kerr Douglas
May 14, 2026 4:05 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: May 13 Filed by: Lucera Erick
May 14, 2026 4:04 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: May 13 Filed by: Cox John
May 14, 2026 4:04 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Cox John
May 13, 2026 4:57 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Lucera Erick
May 13, 2026 4:55 PM - SEC Filing
Dyne Therapeutics to Participate in Upcoming Investor Conferences
May 13, 2026 7:32 AM - StreetInsider
Dyne Therapeutics to Participate in Upcoming Investor Conferences
May 13, 2026 7:30 AM - Globe NewsWire
Dyne Therapeutics (DYN) PT Raised to $24 at Bernstein SocGen Group
May 13, 2026 7:15 AM - StreetInsider
Dynegy (DYN) Tops Q1 EPS by 4c
May 11, 2026 7:53 AM - StreetInsider
Form 8-K Dyne Therapeutics, Inc. For: May 11
May 11, 2026 7:35 AM - SEC Filing
Dyne Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 11, 2026 7:34 AM - StreetInsider
Dyne Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 11, 2026 7:30 AM - Globe NewsWire
Form 10-Q Dyne Therapeutics, Inc. For: Mar 31
May 11, 2026 7:26 AM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: May 04 Filed by: Rhodes Jason P
May 6, 2026 5:10 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
May 6, 2026 4:44 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
May 6, 2026 4:43 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
May 6, 2026 4:43 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
May 6, 2026 4:42 PM - SEC Filing
Form SCHEDULE 13G Dyne Therapeutics, Inc. Filed by: FMR LLC
May 6, 2026 11:14 AM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
May 5, 2026 4:39 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
May 5, 2026 4:37 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
May 5, 2026 4:37 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
May 5, 2026 4:37 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
May 4, 2026 5:01 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
May 4, 2026 5:00 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
May 4, 2026 4:59 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
May 4, 2026 4:59 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Apr 28 Filed by: Rhodes Jason P
April 30, 2026 5:22 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Apr 24 Filed by: Lubner David Charles
April 28, 2026 4:57 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
April 28, 2026 4:44 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
April 28, 2026 4:44 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
April 28, 2026 4:43 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
April 28, 2026 4:43 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Apr 23 Filed by: Rhodes Jason P
April 27, 2026 6:16 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
April 27, 2026 4:50 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
April 27, 2026 4:49 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
April 27, 2026 4:49 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
April 27, 2026 4:48 PM - SEC Filing
Dyne Therapeutics Announces Upcoming Presentation Highlighting Robust CNS Activity in Nonhuman Primates with its FORCE™ Platform at 2026 ASGCT Annual Meeting
April 27, 2026 4:34 PM - Globe NewsWire
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
April 24, 2026 4:47 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
April 24, 2026 4:47 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
April 24, 2026 4:46 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
April 24, 2026 4:46 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
April 23, 2026 7:19 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
April 23, 2026 7:19 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
April 23, 2026 7:19 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
April 23, 2026 7:19 PM - SEC Filing
Form ARS Dyne Therapeutics, Inc. For: Dec 31
April 23, 2026 7:09 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Apr 21 Filed by: Kersten Dirk
April 23, 2026 7:09 PM - SEC Filing
Form DEFA14A Dyne Therapeutics, Inc.
April 23, 2026 7:09 PM - SEC Filing
Form DEF 14A Dyne Therapeutics, Inc. For: Apr 22
April 23, 2026 7:08 PM - SEC Filing
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 23, 2026 4:05 PM - StreetInsider
Form 4 Dyne Therapeutics, Inc. For: Apr 20 Filed by: Rhodes Jason P
April 22, 2026 6:27 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
April 22, 2026 4:54 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
April 22, 2026 4:54 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
April 22, 2026 4:53 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
April 22, 2026 4:53 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
April 21, 2026 4:54 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
April 21, 2026 4:54 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
April 21, 2026 4:53 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
April 21, 2026 4:53 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Apr 17 Filed by: Kersten Dirk
April 21, 2026 4:15 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Dyne Therapeutics (DYN)
April 21, 2026 6:37 AM - StreetInsider
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
April 20, 2026 4:44 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
April 20, 2026 4:44 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
April 20, 2026 4:44 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Associates XI, L.P.
April 20, 2026 4:44 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Apr 15 Filed by: Kersten Dirk
April 17, 2026 4:05 PM - SEC Filing
Bernstein on US Pharma and Biotech: Who might buy whom?
April 13, 2026 5:52 AM - StreetInsider
Form PRE 14A Dyne Therapeutics, Inc. For: Apr 09
April 9, 2026 4:30 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Apr 01 Filed by: Lucera Erick
April 3, 2026 4:10 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Mar 30 Filed by: Posner Brian S
April 1, 2026 4:28 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: Lucera Erick
April 1, 2026 4:06 PM - SEC Filing
Dyne Therapeutics Announces Participation at 2026 Academy of Managed Care Pharmacy (AMCP) Conference to Begin Shaping Access in US for Potential Neuromuscular Medicines
April 1, 2026 7:30 AM - StreetInsider
Form S-8 Dyne Therapeutics, Inc.
March 27, 2026 4:15 PM - SEC Filing
Form SCHEDULE 13G/A Dyne Therapeutics, Inc. Filed by: VANGUARD GROUP INC
March 26, 2026 6:05 PM - SEC Filing
Raymond James Reiterates Strong Buy Rating on Dyne Therapeutics (DYN)
March 25, 2026 3:21 PM - StreetInsider
RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'
March 18, 2026 9:21 AM - StreetInsider
Form 4 Dyne Therapeutics, Inc. For: Mar 11 Filed by: Posner Brian S
March 13, 2026 4:47 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Mar 11 Filed by: Kersten Dirk
March 13, 2026 4:36 PM - SEC Filing
Form 4 Dyne Therapeutics, Inc. For: Mar 09 Filed by: Kersten Dirk
March 11, 2026 5:27 PM - SEC Filing
Form 144 Dyne Therapeutics, Inc. Filed by: ForDyne B.V.
March 11, 2026 4:06 PM - SEC Filing
Full Article List
